Skip to content
Home
About Us
Our Technology
Our Research
Catuvab®
News
Contact Us
Business Development
Imprint
Privacy Policy
About Us
Our Company
Our Team
Management
Scientific Advisory Board
Technology
Our Science
Our Research
Our Products
CATUVAB
News
Business Development
About Us
Our Company
Our Team
Management
Scientific Advisory Board
Technology
Our Science
Our Research
Our Products
CATUVAB
News
Business Development
Contact Us
Blog
Latest news
Learn more about our most recent press releases, conference attendances or explore our public downloads.
CATUVAB®: Final REMOVE Study Results Published in Journal of Clinical Anesthesia
1 year ago
Read more
New Multicenter Study Confirms: CATUVAB® Safely Removes Tumor Cells from Salvaged Blood
1 year ago
Read more
Successful Financing
2 years ago
Read more
Positive Top Line Results
2 years ago
Read more
Top Line Results presentation at NATA24
3 years ago
Read more
Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study
3 years ago
Read more
Lindis Blood Care Establishes Scientific Advisory Board of Leading Industry Experts
4 years ago
Read more
Lindis Blood Care successfully closes follow-on financing round
5 years ago
Read more
Lindis Blood Care Announces Publication of Clinical Pilot Study Results
5 years ago
Read more
Tumorzellfreies Eigenblut bei Krebsoperationen
5 years ago
Read more
Lindis’ Catuvab is designed to remove tumor cells from surgical blood
6 years ago
Read more
Lindis Initiates Clinical EU Certification Study REMOVE with CATUVAB®
6 years ago
Read more
Over 5 million euros for Lindis Blood Care
7 years ago
Read more
